Screener
Indivior Pharmaceuticals, Inc. INDV Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s current ratio?
- Indivior Pharmaceuticals, Inc. (INDV) reported current ratio of 0.9× in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s current ratio decreased by 2.5% year-over-year, from 0.9× to 0.9×.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s current ratio?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s current ratio has grown at a -14.7% compound annual growth rate (CAGR), from 1× to 0.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Indivior Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude